We are live on ! Find out more
DF

DC Funds Portfolio holdings

AUM $1.49M
1-Year Est. Return 18.57%
This Fund
S&P 500
This Quarter Est. Return
+13.48%
1 Year Est. Return
-18.57%
3 Year Est. Return
-38.34%
5 Year Est. Return
-87.14%
10 Year Est. Return
AUM
$4.86M
AUM Growth
+$163K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRNS
1
Barinthus Biotherapeutics
BRNS
$22.8M
$1.98M 40.85%
642,204
TCRX icon
2
TScan Therapeutics
TCRX
$48.6M
$1.61M 33.2%
630,000
HOWL icon
3
Werewolf Therapeutics
HOWL
$17.2M
$1.26M 25.95%
589,102

Similar funds

DC Funds's Q3 2023 Portfolio in Review

As of Q3 2023, DC Funds held 3 positions worth $4.86M, up 3.5% from $4.69M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 0%. DC Funds opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • DC Funds's ten largest holdings make up 100% of its $4.86M portfolio in Q3 2023.
  • DC Funds opened 0 new positions and closed 0 in Q3 2023.
  • DC Funds's portfolio value rose 3.5% quarter-over-quarter to $4.86M.

Based on DC Funds's 13F filing for Q3 2023, filed 14 Nov 2023.